跳至主要内容
临床试验/NCT00581906
NCT00581906
进行中(未招募)
不适用

Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 272 人2006年2月1日

概览

阶段
不适用
干预措施
DCE-MRI, DW-MRI and MRS
疾病 / 适应症
Head and Neck Cancer
发起方
Memorial Sloan Kettering Cancer Center
入组人数
272
试验地点
1
主要终点
Identify a priori prognostic markers for head and neck cancer patients using DCE-MRI, DW-MRI and 1H-MRS data, which may help in stratifying patients into "good risk" and "poor risk" categories to improve outcome and quality of life.
状态
进行中(未招募)
最后更新
上个月

概览

简要总结

Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the body using magnetic field and radio frequency pulses that can not be felt. Dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI) uses faster imaging and contrast material (a substance used to make specific organs, blood vessels, or tumors easier to see) that is given by vein. Diffusion weighted magnetic resonance imaging (DW-MRI) allows to measure the motion of water around the cells in the tumor. Proton magnetic resonance spectroscopy (MRS) obtains chemical information from the tumor. During MRS, signals are detected from the chemicals (spectroscopy) naturally present in your tumor using radio waves. DCE-MRI, DW-MRI and MRS give extra information which is not available with the regular MRI. The regular MRI only shows pictures of the tumor while the DCE-MRI also gives information about the blood vessels of the tumor. DW-MRI provides information related to the state of the tumor tissue with regards to the quality or condition of cells present in it and MRS gives information about the chemical makeup of the tumor.

The purpose of this study is to see whether DCE-MRI, DW-MRI and MRS done before treatment can predict which patients will do well with either surgery or chemo-radiation therapy. This study will also see if DCE-MRI, DW-MRI and MRS done early in treatment can tell if the therapy is working.

注册库
clinicaltrials.gov
开始日期
2006年2月1日
结束日期
2027年2月1日
最后更新
上个月
研究类型
Observational
性别
All

研究者

入排标准

入选标准

  • Patients with histologically proven diagnosis of head and neck cancer or patients with tumors strongly suspicious for head and neck cancer due to clinical features or FNA (fine needle aspiration) cytology assessment.
  • Will undergo surgery or chemo-radiation treatment
  • Patients must be 18 years or older and have the ability to give informed consent

排除标准

  • Claustrophobia
  • Known reaction to Gd-DTPA
  • Pre-operative radiation to primary tumor site
  • Contraindication to MRI
  • Aneurysmal clips
  • Metal implants in field of view
  • Pregnant or nursing women
  • Age and mental status wherein he/she is unable to cooperate for MRI study

研究组 & 干预措施

pts undergoing surgery or chemo-radiation treatment

干预措施: DCE-MRI, DW-MRI and MRS

结局指标

主要结局

Identify a priori prognostic markers for head and neck cancer patients using DCE-MRI, DW-MRI and 1H-MRS data, which may help in stratifying patients into "good risk" and "poor risk" categories to improve outcome and quality of life.

时间窗: 5 years

次要结局

  • To determine if the a-priori DCE-MRI, DW-MRI and 1H-MRS results provide independent markers of tumor response and/or long term disease-free survival compared to clinical prognosticators.(5 years)

研究点 (1)

Loading locations...

相似试验